IL-18 is not therapeutic for neovascular age-related macular degeneration

Yoshio Hirano, Tetsuhiro Yasuma, Takeshi Mizutani, Benjamin J. Fowler, Valeria Tarallo, Reo Yasuma, Younghee Kim, Ana Bastos-Carvalho, Nagaraj Kerur, Bradley D. Gelfand, Sasha Bogdanovich, Shikun He, Xiaohui Zhang, Miho Nozaki, Ryo Ijima, Hiroki Kaneko, Yuichiro Ogura, Hiroko Terasaki, Hiroshi Nagai, Isao HaroGabriel Núfez, Balamurali K. Ambati, David R. Hinton, Jayakrishna Ambati

Research output: Contribution to journalLetterpeer-review

35 Scopus citations
Original languageEnglish
Pages (from-to)1372-1375
Number of pages4
JournalNature Medicine
Volume20
Issue number12
DOIs
StatePublished - Dec 1 2014

Bibliographical note

Funding Information:
We thank L. Toll, G.R. Pattison R. King, L. Xu, M. McConnell, C. Payne, D. Robertson, G. Botzet, K. Ambati and A. Uittenbogaard for technical assistance. J.A. was supported by National Eye Institute/US National Institutes of Health (NIH) grants DP1GM114862, R01EY018350, R01EY018836, R01EY020672 and R01EY022238, the Doris Duke Distinguished Clinical Scientist Award, the Burroughs Wellcome Fund Clinical Scientist Award in Translational Research, the Ellison Medical Foundation Senior Scholar in Aging Award, the Dr. E. Vernon Smith and Eloise C. Smith Macular Degeneration Endowed Chair, a Foundation Fighting Blindness Individual Investigator Research Award, the Carl Reeves Foundation, a Harrington Discovery Institute Scholar-Innovator Award and a Research to Prevent Blindness departmental unrestricted grant. Y.H. was supported by an Alcon Japan Research award. T.Y. was supported by a Fight for Sight postdoctoral award. B.J.F. was supported by NIH T32HL091812 and UL1RR033173. A.B.-C. was supported by the Programme for Advanced Medical Education (sponsored by Fundação Calouste Gulbenkian, Fundação Champalimaud, Ministério da Saúde and Fundação para a Ciência e Tecnologia, Portugal) and a Bayer Global Ophthalmology Research Award. N.K. was supported by NIH K99EY024336 and the Beckman Initiative for Macular Research. B.D.G. was supported by the American Heart Association and the International Retinal Research Foundation. B.K.A. was supported by NIH R01EY017182 and R01EY017950, a Veterans Affairs Merit Award and the Department of Defense. G.N. was supported by NIH R01AI063331 and R01AR052756. D.R.H. was supported by NIH P30EY003040 and R01EY001545 and the Arnold and Mabel Beckman Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'IL-18 is not therapeutic for neovascular age-related macular degeneration'. Together they form a unique fingerprint.

Cite this